MC

577

-0.1%↓

SANES

6.3

-0.14%↓

BNP

76.85

-1.61%↓

CS.FR

40.35

+1.38%↑

ALV

356.3

+0.45%↑

MC

577

-0.1%↓

SANES

6.3

-0.14%↓

BNP

76.85

-1.61%↓

CS.FR

40.35

+1.38%↑

ALV

356.3

+0.45%↑

MC

577

-0.1%↓

SANES

6.3

-0.14%↓

BNP

76.85

-1.61%↓

CS.FR

40.35

+1.38%↑

ALV

356.3

+0.45%↑

MC

577

-0.1%↓

SANES

6.3

-0.14%↓

BNP

76.85

-1.61%↓

CS.FR

40.35

+1.38%↑

ALV

356.3

+0.45%↑

MC

577

-0.1%↓

SANES

6.3

-0.14%↓

BNP

76.85

-1.61%↓

CS.FR

40.35

+1.38%↑

ALV

356.3

+0.45%↑

Search

Eurazeo SE

Avatud

SektorRahandus

66.8 -3.4

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

66.65

Max

69.8

Põhinäitajad

By Trading Economics

Sissetulek

-105M

Müük

104M

Dividenditootlus

3.89

Kasumimarginaal

-100.723

EBITDA

-51M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+46.84% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

3.89%

4.10%

Järgmine tulemuste avaldamine

3. apr 2025

Turustatistika

By TradingEconomics

Turukapital

5.1B

Eelmine avamishind

70.2

Eelmine sulgemishind

66.8

Uudiste sentiment

By Acuity

24%

76%

61 / 542 Pingereas Finance

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

Eurazeo SE Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

11. sept 2024, 06:28 UTC

Omandamised, ülevõtmised, äriostud

EQT Leads $102.5 Million Series A Funding Round in Belgian Radioisotope Producer PanTera

Võrdlus sarnastega

Hinnamuutus

Eurazeo SE Prognoos

Hinnasiht

By TipRanks

46.84% tõus

12 kuu keskmine prognoos

Keskmine 100 EUR  46.84%

Kõrge 100 EUR

Madal 100 EUR

Põhineb 1 Wall Streeti analüütiku instrumendi Eurazeo SE 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

1

Osta

0

Hoia

0

Müü

Tehniline skoor

By Trading Central

67.6 / 71.1Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

61 / 542 Pingereas Rahandus

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Eurazeo SE

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in mid-market and listed public companies. The company invest in equity in the small-mid and Mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. It does not have any restrictions regarding the sectors in which it invests but prefers to invest in smart cities, services, leisure and mobility, real estate, fintech, investment activities, distribution, industry, luxury, consumer goods, business services, consumer and retail brands, and health sectors. The firm seeks to invest in consumer brands with a focus on beauty, personal care, household care, juvenile products, apparel, wellness, accessories, home, jewellery, leisure, health, fitness, beverage, and food companies based in United States and Europe. It typically invests in companies with a differentiated concept and global growth potential. The firm identifies companies upstream, carefully selecting them primarily from sectors driven by digital transformation and focusing on changes in lifestyle and consumption (mobility, online buying, collaboration models, etc. The firm invests in large properties in need of restructuring; residential, commercial, and office development projects; and companies with real estate assets in Western Europe. It primarily invests in United States, France, Italy, North America and other European countries. It seeks to invest between "50 million ($54.35 million) to "250 million ($271.77 million) in small mid buyout business. It seeks to invest between "25 million ($27.18 million) to "100 million ($108.71 million) in growth business. It seeks to invest between "10 million ($10.82 million) and "40 million ($43.82 million) in the fields of healthcare research. It seeks to invests between equity investment between "1 million ($1.17 million) and "559.01 mil